Fulgent Genetics's market cap is currently $508.66M. The company's EPS TTM is $-5.527; its P/E ratio is ―; Fulgent Genetics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 289.21M	$ 618.97M	$ 992.58M	$ 421.71M	$ 32.53M
Gross Profit	$ 104.46M	$ 366.90M	$ 777.05M	$ 331.90M	$ 18.42M
Operating Income	$ -72.69M	$ 178.53M	$ 675.95M	$ 290.16M	$ -428.00K
EBITDA	$ -46.55M	$ 221.59M	$ 675.95M	$ 290.16M	$ 1.68M
Net Income	$ -167.82M	$ 143.40M	$ 507.36M	$ 214.31M	$ 366.00K
Balance Sheet
Cash & Short-Term Investments	$ 424.15M	$ 852.88M	$ 935.55M	$ 431.87M	$ 70.22M
Total Assets	$ 1.24B	$ 1.39B	$ 1.28B	$ 700.46M	$ 88.76M
Total Debt	$ 15.25M	$ 20.64M	$ 21.28M	$ 15.85M	$ 2.68M
Net Debt	$ -82.22M	$ -58.87M	$ -143.61M	$ -71.57M	$ -9.29M
Total Liabilities	$ 102.04M	$ 116.18M	$ 112.84M	$ 131.07M	$ 5.98M
Stockholders' Equity	$ 1.14B	$ 1.27B	$ 1.17B	$ 569.39M	$ 82.78M
Cash Flow
Free Cash Flow	$ 4.80M	$ 234.75M	$ 514.73M	$ 104.12M	$ 4.20M
Operating Cash Flow	$ 27.00M	$ 253.52M	$ 538.58M	$ 140.63M	$ 5.52M
Investing Cash Flow	$ 38.90M	$ -261.31M	$ -546.55M	$ -326.44M	$ -29.05M
Financing Cash Flow	$ -47.78M	$ -77.14M	$ 85.39M	$ 261.25M	$ 28.77M

Currency in USD

Fulgent Genetics Earnings and Revenue History

Income Statement >

Fulgent Genetics Debt to Assets

Balance Sheet >

Fulgent Genetics Cash Flow

Cash Flow >

Fulgent Genetics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing